ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1157

Bacterial Indole Associated with Spondyloarthritis-Related Dysbiosis Contributes to Enhanced Th17 Immunity

Brenda Seymour1, Brandon Trent2, Brendan Allen3, Adam Berlinberg1 and Kristi Kuhn3, 1University of Colorado Anschutz Medical Campus, Denver, CO, 2University of Colorado Anschutz Medical Campus, Eugene, OR, 3University of Colorado Anschutz Medical Campus, Aurora, CO

Meeting: ACR Convergence 2022

Keywords: cytokines, metabolomics, microbiome, spondyloarthritis, TH17 Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: While intestinal dysbiosis and the Th17 pathway are linked to the pathophysiology of spondyloarthritis (SpA), the mechanisms by which this occurs are unknown. We previously linked through microbiome metagenome and intestinal metabolome analyses the presence of indoles derived from bacterial metabolism of tryptophan (Trp) in patients with SpA. We then utilized the collagen-induced arthritis (CIA) model to investigate the role of indole in inflammatory arthritis because the Th17 pathway is required for CIA. We demonstrated that both the microbiome and dietary Trp are required for CIA, and that indole supplementation in either a Trp-deficient or microbiome-deficient setting fulfills this requirement. This led us to hypothesize that indole promotes inflammatory arthritis through enhanced Th17 immunity.

Methods: 6wk-old male DBA/1J mice were maintained on either a Trp-sufficient (TS, 0.18% Trp) or Trp-low (TL, 0.05% Trp) diet. CIA was induced by immunization of bovine type II collagen emulsified in CFA at days 0 and 21. 10 mM indole or vehicle was gavaged in TL mice every other day starting at day 0. In some experiments, 100µg of anti-IL23p19 or isotype was administered on days 0, 7, 14, and 21. CIA severity was assessed from days 21-35+, and on day 35 tissues were analyzed by flow cytometry and multiplex immunoassay. GM-CSF-derived bone marrow dendritic cells (BMDCs) were stimulated with LPS ± 1 mM indole for 24hr. Healthy human colon tissue was homogenized and stimulated with 1mM indole for 4hr, and RNA was isolated from flow-sorted CD3+ T cells and CD19+ B cells for RNAseq. Differentially expressed pathways were identified with Ingenuity Pathway Analysis.

Results: We first tested the effect of indole on Th17-promoting cytokines and Th17 cells in CIA and observed significant increases in serum IL-6, TNF, and IL-1β and splenic Th17 cells in TL + Indole mice compared to TL + Vehicle (Fig. 1A-D). We then tested the requirement for IL-23, which promotes pathogenic Th17 differentiation, and found that administration of anti-IL-23 significantly reduced CIA severity in TL + Indole mice (Fig. 1E). To investigate the source of IL-23 and other Th17-promoting cytokines, we stimulated BMDCs with LPS ± indole and saw significant increases in IL-6, TNF, IL-1β, and IL-23 with indole + LPS compared to LPS alone (Table 1). Finally, we tested the effect of indole on human colon lymphocytes and saw increased expression of genes involved in the IL-17 signaling pathway in indole-stimulated B cells (93/187 genes, p=0.02, z=3.87) and T cells (100/187 genes, p=0.02, z=4.36) compared to unstimulated controls (Fig. 2).

Conclusion: Altogether, we show that indole enhances production of Th17-promoting cytokines IL-6, IL-1β, and TNF in BMDCs and in the serum of TL + indole CIA mice. While IL-23 was undetectable in the serum, it was significantly elevated in indole + LPS BMDCs, and treatment with anti-IL-23 reduced CIA severity in TL + Indole mice. Future studies will identify Th17-promoting DC subsets in TL + Indole mice. Finally, enhanced IL-17 signaling in human colon lymphocytes provides proof of concept that indole enhances the Th17 pathway in both mouse and human, providing an opportunity to define and intervene in this pathway to block SpA development.

Supporting image 1

Figure 1. The role of Th17-promoting cytokines in CIA. CIA was induced in TL + vehicle, TL + indole, or TS + vehicle mice (n=6_20). On day 35, serum cytokines were assessed by multiplex immunoassay (A-C) and splenic RORγt+ Th17 cells and FoxP3+ Tregs were quantified by flow cytometry (D). Alternatively, anti-IL23 or isotype were administered to TL + Indole mice (n=10) and disease severity was assessed through day 52.

Supporting image 2

Table 1. GM-CSF-derived BMDCs were stimulated with LPS +/- indole for 24hr. Supernatant was analyzed by ELISA and RNA was analyzed by RT-qPCR.

Supporting image 3

Figure 2. Healthy human colon tissue was homogenized and stimulated with 1mM indole for 4hr; CD3+ T cells and CD19+ B cells were flow sorted and RNA was harvested for RNAseq. IPA pathway analysis revealed differentially expressed pathways.


Disclosures: B. Seymour, None; B. Trent, None; B. Allen, None; A. Berlinberg, None; K. Kuhn, None.

To cite this abstract in AMA style:

Seymour B, Trent B, Allen B, Berlinberg A, Kuhn K. Bacterial Indole Associated with Spondyloarthritis-Related Dysbiosis Contributes to Enhanced Th17 Immunity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/bacterial-indole-associated-with-spondyloarthritis-related-dysbiosis-contributes-to-enhanced-th17-immunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bacterial-indole-associated-with-spondyloarthritis-related-dysbiosis-contributes-to-enhanced-th17-immunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology